M28 Capital Management LP reported 9 holdings worth US$47.2M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
M28 Capital Management LP reported 9 holdings worth US$47.2M as of Jun 30, 2026. Largest: Invivyd, Inc., Tg Therapeutics, Inc. and Arrowhead Pharmaceuticals, Inc. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 9
- Value as reported
- US$47.2M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|---|---|---|
| Invivyd, Inc. | 9.25M | US$8.07M | 17.1% |
| Tg Therapeutics, Inc. | 88,354 | US$4.85M | 10.3% |
| Arrowhead Pharmaceuticals, Inc. | 36,851 | US$3M | 6.4% |
| Fractyl Health, Inc. | 1.86M | US$1.47M | 3.1% |
| Rocket Pharmaceuticals, Inc. | 211K | US$721K | 1.5% |
| Curis, Inc. | 285K | US$149K | 0.32% |